Search For "us food and drug administration"
Bharat Biotech's partner seeks Covaxin approval in US for children below 1
Updated : 4 years, 4 months ago IST
New Delhi [India], November 6 (ANI): Bharat Biotech's US partner Ocugen has announced that it had asked the US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of Covaxin for children below 18.
Read More
COVID-19: Biden urges parents, guardians of children ages 5 and older to g
Updated : 4 years, 4 months ago IST
Washington [US], November 4 (ANI): Following formal recommendation of the Pfizer COVID-19 vaccine for children 5-11 by the US Food and Drug Administration (FDA), and the Centers for Disease Control (CDC), US President Joe Biden on Thursday (local time) urged parents and guardians to get thei
Read More
US formally recommends Pfizer COVID-19 vaccine for children aged 5-11
Updated : 4 years, 4 months ago IST
Washington [US], November 3 (ANI): Following rigorous review and authorization process by the US Food and Drug Administration (FDA), the Centers for Disease Control (CDC) on Tuesday (local time) has formally recommended the Pfizer COVID-19 vaccine for children 5-11.
Read More
US-FDA's approval of mix and match COVID booster shots confirmation of eff
Updated : 4 years, 5 months ago IST
Moscow [Russia], October 21 (ANI): Following the decision by the US Food and Drug Administration allowing individuals to receive booster shots that are different from their first COVID-19 vaccine doses, the Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) reiterated that
Read More
FDA takes additional actions on use of booster dose for COVID-19 vaccines
Updated : 4 years, 5 months ago IST
Washington [US], October 21 (ANI): The US Food and Drug Administration (FDA) approved the use of third doses of the Moderna and Johnson and Johnson (Janssen) vaccines against the novel COVID-19 for eligible individuals.
Read More
US FDA authorizes Pfizer's Covid booster shots for elderly, high-risk Amer
Updated : 4 years, 5 months ago IST
Washington [US], September 23 (ANI): US Food and Drug Administration (FDA) on Wednesday (local time) authorized booster shots of the Pfizer COVID-19 vaccine for those aged 65 and older and adults at high risk.
Read More
US FDA: No Pfizer booster shots for 16 and above, approved only for people
Updated : 4 years, 6 months ago IST
Washington [US], September 18 (ANI): The US Food and Drug Administration advisory (FDA) committee on Friday (local time) voted unanimously to authorize Pfizer booster shots for use in people aged 65-plus and high-risk patients following a prior failed vote to approve third shots for all p
Read More
US: FDA gives full approval to Pfizer-BioNTech COVID 19 vaccine
Updated : 4 years, 6 months ago IST
Washington [US] August 23 (ANI): The US Food and Drug Administration (FDA) on Monday gave full approval to Pfizer's COVID-19 vaccine.
Read More
Immunocompromised people in US to get 3rd dose of COVID-19 vaccines
Updated : 4 years, 7 months ago IST
Washington [US], August 13 (ANI/Sputnik): The US Food and Drug Administration (FDA) has authorized the emergency use of the third dose of both Moderna and Pfizer vaccines against COVID-19 for immunocompromised people.
Read More
Jubilant Pharma's rating headroom healthy despite import alert for India p
Updated : 4 years, 7 months ago IST
Singapore, July 26 (ANI): Jubilant Pharma Ltd (JPL) will continue to maintain good rating headroom as the impact of a recent US Food and Drug Administration import alert for its generic formulations plant in India will be limited, Fitch Ratings has said.
Read More
FDA warns of rare neurological complication with J&J coronavirus vacci
Updated : 4 years, 8 months ago IST
Washington [US], July 13 (ANI): The US Food and Drug Administration (FDA) on Monday (local time) warned coronavirus vaccine maker Johnson & Johnson of possible rare neurological complications caused due to its dose.
Read More
Third member of US FDA advisory panel resigns over Alzheimer's drug approv
Updated : 4 years, 9 months ago IST
Washington [US], June 11 (ANI): A third member of the US Food and Drug Administration (FDA) expert advisory panel resigned from the body after it approved a controversial Alzheimer's drug named Aduhelm recently.
Read More